Telos Capital Management, Inc. Eli Lilly & CO Transaction History

Telos Capital Management, Inc.

$937 Million
Q3 2024

A detailed history of Telos Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Telos Capital Management, Inc. holds 1,616 shares of LLY stock, worth $1.29 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,616

Previous 1,616 -0.0%

Holding current value

$1.29 Million

Previous $1.46 Million 2.19%

% of portfolio

0.15%

Previous 0.16%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $50,740 - $63,632	-70 Reduced 4.15%	1,616 $1.46 Million
Q1 2024 Apr 24, 2024	SELL	$592.2 - $792.28 $2.28 Million - $3.05 Million	-3,855 Reduced 69.57%	1,686 $1.31 Million
Q4 2023 Jan 30, 2024	SELL	$525.19 - $619.13 $84,030 - $99,060	-160 Reduced 2.81%	5,541 $3.23 Million
Q2 2023 Jul 20, 2023	SELL	$350.74 - $468.98 $55,767 - $74,567	-159 Reduced 2.71%	5,701 $2.67 Million
Q1 2023 Apr 27, 2023	SELL	$310.63 - $364.82 $1,553 - $1,824	-5 Reduced 0.09%	5,860 $2.01 Million
Q4 2022 Jan 27, 2023	SELL	$321.55 - $374.67 $56,914 - $66,316	-177 Reduced 2.93%	5,865 $0
Q3 2022 Oct 31, 2022	SELL	$296.48 - $337.87 $333,540 - $380,103	-1,125 Reduced 15.7%	6,042 $1.95 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $23,469 - $29,166	-100 Reduced 1.38%	7,167 $2.05 Million
Q4 2021 Jan 21, 2022	SELL	$224.85 - $279.04 $22,485 - $27,904	-100 Reduced 1.36%	7,267 $2.01 Million
Q2 2021 Jul 15, 2021	SELL	$180.55 - $233.54 $313,254 - $405,191	-1,735 Reduced 19.06%	7,367 $1.69 Million
Q1 2021 Apr 28, 2021	BUY	$164.32 - $212.72 $26,291 - $34,035	160 Added 1.79%	9,102 $1.7 Million
Q4 2020 Feb 02, 2021	BUY	$130.46 - $172.63 $5,218 - $6,905	40 Added 0.45%	8,942 $1.51 Million
Q2 2020 Jul 23, 2020	SELL	$136.42 - $164.18 $6,820 - $8,209	-50 Reduced 0.56%	8,902 $1.46 Million
Q1 2020 May 01, 2020	BUY	$119.05 - $147.35 $671,203 - $830,759	5,638 Added 170.13%	8,952 $1.24 Million
Q4 2019 Jan 23, 2020	BUY	$106.92 - $132.43 $26,730 - $33,107	250 Added 8.16%	3,314 $436,000
Q3 2019 Oct 31, 2019	BUY	$106.79 - $116.16 $94,295 - $102,569	883 Added 40.49%	3,064 $343,000
Q2 2019 Jul 19, 2019	SELL	$110.79 - $129.32 $8,863 - $10,345	-80 Reduced 3.54%	2,181 $242,000
Q1 2019 Apr 18, 2019	SELL	$111.31 - $131.02 $13,913 - $16,377	-125 Reduced 5.24%	2,261 $293,000
Q4 2018 Jan 31, 2019	BUY	$105.9 - $118.64 $20,226 - $22,660	191 Added 8.7%	2,386 $276,000
Q3 2018 Oct 26, 2018	SELL	$85.86 - $107.31 $25,758 - $32,193	-300 Reduced 12.02%	2,195 $236,000
Q2 2018 Jul 27, 2018	BUY	$75.7 - $86.88 $188,871 - $216,765	2,495 New	2,495 $213,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Telos Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Telos Capital Management, Inc. with notifications on news.

Account

Telos Capital Management, Inc. Eli Lilly & CO Transaction History